权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Role of Chrna5 genotype on outcomes of developmental nicotine exposure

Chrna5 基因型对发育期尼古丁暴露结果的作用

基本信息

批准号：
8950029
负责人：
JERRY A STITZEL
金额：
$ 22.38万
依托单位：
UNIVERSITY OF COLORADO
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-07-01 至 2017-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8950029
关键词：
Acetylcholine Address Adolescence Adolescent Affect Amino Acids Area Behavior Behavioral Brain Child Consumption Data Development Environment Exhibits Exposure to Genes Genetic Genetic Polymorphism Genetic Risk Genetic Variation Genotype Goals Habenula Heterozygote Human Human Genetics Inherited Intake Investigation Laboratories Lateral Measures Mediating Morphology Mothers Mus Names Neurons Nicotine Nicotine Dependence Nicotinic Receptors Nucleus Accumbens Outcome Pathway interactions Perinatal Exposure Pharmaceutical Preparations Play Pregnancy Pregnant Women Property Protein Subunits Pyramidal Cells Reporting Rewards Risk Risk Factors Rodent Role Smoke Smoker Smoking Structure Testing Tobacco Tobacco use Variant Woman conditioning fetal tobacco exposure genetic variant hippocampal pyramidal neuron in utero insight motivated behavior mouse model neurophysiology novel offspring pregnant public health relevance research study response risk variant smoking cessation

项目摘要

DESCRIPTION (provided by applicant): Despite warnings of the teratogenic effects of tobacco use during pregnancy, estimates show that between 15 and 30% of all pregnant women in the US smoke. This leads to an alarming 700,000 children each year that are exposed to tobacco constituents in utero. Among the many reported negative outcomes of in utero nicotine exposure is a 3-5 fold elevated risk for the development of nicotine dependence. Rodent studies have supported the findings that developmental nicotine exposure increases negative outcomes, including increased risk for nicotine consumption. The mechanism(s) underlying the increased rate of smoking among in utero exposed children have not been elucidated. However, the women most prone to continue smoking during pregnancy are those at elevated genetic risk for nicotine dependence. Therefore, the elevated risk of nicotine dependence in their offspring could be due to inherited risk factors, in utero exposure, or both. Our laboratory recently has developed a mouse model that carries a human genetic variation in a gene named CHRNA5. Importantly for this application, women who have the risk version of this gene are less likely to stop smoking during pregnancy. Preliminary data from the mouse model indicate that mice with the risk version of the gene and exposed to nicotine in utero will consume the highest levels of nicotine suggesting an additive effect of genetic risk and environment. Strikingly and unexpectedly, however, offspring with the non-risk variant that were developmentally exposed to nicotine exhibited a dramatic reduction in nicotine intake during adolescence as compared to their genotype matched controls. This novel finding indicates that the direction of effect of developmental nicotine exposure on subsequent risk for nicotine intake is genotype dependent and challenges the notion that prenatal nicotine exposure alone is a risk factor for the development of nicotine dependence. To better appreciate how genotype and developmental nicotine exposure interact to dramatically alter outcomes, this exploratory project proposes two specific aims. Because alterations in nicotine consumption can be through altered reward or/and aversion to nicotine, we will determine the impact of nicotine exposure and genotype on these motivated behaviors. We also will assess whether the interaction between genotype and nicotine exposure to alter nicotine intake is due to the genotype of the offspring. In addition, we will assess the effect of genotype and prenatal nicotine exposure on the functional properties and structure of layer VI prefrontal cortical pyramidal cells that project to select brain areas relevant to reward and aversion. Understanding how genotype modifies the effect of developmental nicotine exposure on nicotine reward and brain circuits that modulate these behaviors will provide unique insight into the behavioral and neurophysiological mechanisms through which prenatal nicotine exposure alters risk for nicotine dependence.